VAERS 1400385
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge IN ERROR ENTRY
- Staat
- NY
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 15.06.2021
- Impfdatum
- 10.06.2021
- Beginn
- 11.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- OT / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Symptomtext
16 year old male with no PMH who presented with chest pain. Initially on 6/10-6/11 had expected myalgias and headaches post vaccination similar to dose #1, but later 6/11 developed chest pain that made it impossible for him to sleep. It was waxing and waning but continued through 6/12 which after discussion with PMD ultimately led to referral into our facility for further evaluation. Received a dose of ibuprofen with marked symptomatic relief. No further medications given during his time, his chest pain had resolved after that ibuprofen dose and was at clinical baseline until discharge on 6/15. Prolonged hospital course was to arrange for cardiac MRI to be done for comparison. Otherwise had serial labs (documented below) which had trended in the right direction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 3,0
- Labordaten
- 6/13/2021: CBC with differential (WBC 4.8, RBC 5.76, HgB 16.3, Hct 48.2, platelets 193, 42.4% neutrophils, 33.3% lymphocytes, 13.2% onocytes, 9.7% eosinophils, 1% basophils. 0.4% immature granulocytes) ESR 5, CRP 51.27. BMP (sodium 141, potassium 4.4, chloride 108, Bicarb 21, BUN 7, Creatinin 0.81, Calcium 9.4, glucose 93). 6/13/21 early morning Cardiac Enzymes: Troponin I POC 2.76 ng/mL, CKMB 17.6 ng/mL, myoglobin >500ng/mL. 6/13/21 late morning Troponin I: 2.56ng/mL 6/14/21 troponin I: 1.35ng/mL 6/13 Respiratory viral panel: negative for Influenza A, Influenza B, RSV, Parainfluenza 1-4, Adenovirus, human metapneumovirus, and SARS-CoV-2. 6/13 SARS-CoV-2 IgG: <1.4 (negative) 6/13 Mycoplasma IgG: 1.30 (positive) 6/13 ASO: 146 unit/mL (normal) 6/13 Pending infectious disease tests: Anti-DNaseB titer, Coxsackie A titer, Coxsackie B titer, Mycoplasma IgM, Echovirus antibody 6/13 EKG: Sinus Rhythm with Sinus arrhythmia, Diffuse ST Elevation consistent with injury, pericarditis. 6/14 EKG: Sinus Rhythm with sinus arrhythmia 6/13 Echocardiogram: Structurally normal heart, normal appearing proximal coronary arteries (proximal LCA 3.9mm z -0.05; proximal RCA 3.6mm z 0.4), normal biventricular systolic function. no pericardial effusion. 6/15 cardiac MRI: HISTORY/REASON FOR STUDY: Patient is a 16-year-old boy with suspected vaccination induced myocarditis/pericarditis IMAGING SEQUENCES: Breath hold non-ECG gated 3-plane localizers; breath hold ECG gated 2,4 chamber and short axis ventricular SSFP imaging; Bright and block blood imaging across the chest; T1 myocardial imaging in the short axis pre- and post-contrast; early and delayed myocardial enhancement imaging 5 and 10-15 minutes following intravenous injection of Gadolinium. QUALITY/COMPLICATIONS: The patient was able to hold his breath throughout the study with no significant difficulty. The images are of adequate quality for interpretation. There were no complications related to the study. FINDINGS: CARDIAC MRI STUDY with and without CONTRAST: There is levocardia, levoversion and {S,D,S} normal chamber/vessel interrelationships. Some pulmonary venous return to the left atrium is visualized. Systemic venous returns are normal to the right atrium. The cardiac septa appear intact. There is normal LV size with normal LV mass and no significant wall motion abnormality. The right ventricle is grossly normal in size and systolic function with no segmental wall motion abnormalities or free wall thinning. The cardiac valves appear grossly normal. The outflow tracts are patent. There are no obvious intracardiac masses. There is trace/small pericardial effusion. There are no perfusion defects or areas of myocardial delayed enhancement. Myocardial T1 relaxation times are not abnormally increased. SUMMARY: {S,D,S} normal anatomy. Normal LV function with no segmental wall motion abnormalities, perfusion defects, abnormally increased myocardial T1 relaxation time or areas of delayed myocardial enhancement. Trace/small pericardial effusion.
- Aktuelle Erkrankungen
- No identified recent illnesses.
- Vorgeschichte
- None
- Andere Medikamente
- No medications at that time. Took a few doses of tylenol with minimal relief.
- Allergien
- No known allergies
- Vorherige Impfungen
- -